Additional file 2: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Table S2. Distribution of the PCBaSe study cohort (n = 72,337) by age, serum PSA at presentation, biopsy Grade Group (GG) and clinical stage (PSA in ng/ml). (DOCX 16 kb)